Stocktoria
ESTABLISHMENT LABS HOLDINGS INC. ESTA
ESTABLISHMENT LABS HOLDINGS INC. (ESTA) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $211.1M at a -24.2% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.3 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-05-07 | BTIG | Buy (main) |
| 2026-04-29 | BTIG | Buy (reit) |
| 2026-03-11 | Citigroup | Neutral (main) |
| 2026-02-26 | Canaccord Genuity | Buy (main) |
| 2026-02-25 | Stephens & Co. | Overweight (main) |
| 2026-02-25 | Mizuho | Outperform (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.47 |
| Retained earnings / assets | -1.388 |
| EBIT / assets | -0.109 |
| Equity / liabilities | 0.071 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| ESTA | ESTABLISHMENT LABS HOLDINGS INC. | 4/9 | -2.1 | — | +27.1% |
| LAKE | LAKELAND INDUSTRIES INC | 2/9 | 4.56 | — | +15.2% |
| SMTI | Sanara MedTech Inc. | 4/9 | -1.26 | — | +19% |
| INGN | Inogen Inc | 4/9 | 2.26 | — | +3.9% |
| APT | ALPHA PRO TECH LTD | 4/9 | 12.4 | 16.1 | +2.3% |
| MYO | MYOMO, INC. | 3/9 | -8.82 | — | +25.7% |
| LFWD | Lifeward Ltd. | 4/9 | — | — | -14.1% |
About ESTABLISHMENT LABS HOLDINGS INC.
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.
FAQ
Is ESTA financially healthy?
ESTABLISHMENT LABS HOLDINGS INC.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does ESTA pay a dividend?
No, ESTABLISHMENT LABS HOLDINGS INC. does not currently pay a dividend.
How profitable is ESTA?
In FY2025, ESTABLISHMENT LABS HOLDINGS INC. had a net margin of -24.2% and a return on equity of -216.9%.
What is the analyst price target for ESTA?
The average Wall-Street price target for ESTABLISHMENT LABS HOLDINGS INC. is $91.22, about 20.7% above the recent price, from 9 analysts (consensus: strong buy).
Is ESTA a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on ESTABLISHMENT LABS HOLDINGS INC.: a Piotroski F-score of 4/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.